MARKET

BFRGW

BFRGW

Bullfrog AI Holdings, Inc.
NASDAQ
0.1800
-0.0100
-5.26%
Closed 09:30 02/06 EST
OPEN
0.1800
PREV CLOSE
0.1900
HIGH
0.1800
LOW
0.1800
VOLUME
219
TURNOVER
--
52 WEEK HIGH
1.370
52 WEEK LOW
0.1501
MARKET CAP
--
P/E (TTM)
-0.2595
1D
5D
1M
3M
1Y
5Y
1D
BullFrog AI to Unveil New Precision AI Capability
Barchart · 4d ago
Weekly Report: what happened at BFRGW last week (0126-0130)?
Weekly Report · 6d ago
BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
Barchart · 01/27 06:30
BullFrog AI Holdings Showcases AI-Driven Drug Discovery Platform in New Presentation
Reuters · 01/26 21:23
Weekly Report: what happened at BFRGW last week (0119-0123)?
Weekly Report · 01/26 09:20
Weekly Report: what happened at BFRGW last week (0112-0116)?
Weekly Report · 01/19 09:22
Weekly Report: what happened at BFRGW last week (0105-0109)?
Weekly Report · 01/12 09:21
BullFrog AI Platform Triples Survival Rates in Pancreatic Cancer Patient Subgroups
Reuters · 01/06 12:30
More
About BFRGW
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence / machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Webull offers Bullfrog AI Holdings, Inc. stock information, including NASDAQ: BFRGW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRGW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRGW stock methods without spending real money on the virtual paper trading platform.